MENA clinical trial expansion risks sponsors should plan for

Regional opportunity creates new interfaces

Expansion into Saudi Arabia or Egypt can add sites, local partners, vendors, document flows, languages, time zones, and decision routes. The risk is often not one individual workstream but the handoffs between them.

Operational questions to resolve early

• Who owns each country and startup dependency?
• Which local capabilities require qualification?
• How will global and regional timelines be reconciled?
• What information moves between local partners and sponsor functions?
• Which issues require regional versus global escalation?
• How will time-zone coverage and continuity work?
• What evidence will demonstrate sponsor oversight of regional activity?

Separate operational support from local authority

Operational planning can improve sequencing, interfaces, reporting, and governance. Legal, licensing, medical, and jurisdiction-specific regulatory advice should remain with appropriately qualified local parties.

Create one integrated plan

Country activity should connect to the global program’s risk register, milestone plan, decision process, and reporting cadence. A separate regional tracker that does not feed sponsor decisions can create the appearance of control without actual integration.